The clinical significance of CD4 counts in asian and caucasian HIV-infected populations: Results from TAHOD and AHOD

Journal of the International Association of Physicians in AIDS Care

Volumn 10, Issue 3, 2011, Pages 160-170

  Achhra, Amit C ^a   Zhou, Jialun ^a   Choi, Jun Yong ^b   Hoy, Jennifer ^c   Zhang, Fujie ^d   Templeton, David J ^a,e   Merati, Tuti ^f   Woolley, Ian ^c   Petoumenos, Kathy ^a   Amin, Janaki ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Yonsei University College of Medicine   (South Korea)

^c MONASH UNIVERSITY   (Australia)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f UDAYANA UNIVERSITY   (Indonesia)

Author keywords

Asians; Caucasian race; CD4 counts; cohort analysis; ethnicity

Indexed keywords

ANTIVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ASIAN; AUSTRALIA; CALCULATION; CAUCASIAN; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; ETHNICITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK; ASIA; HIV INFECTIONS;

ANTI-HIV AGENTS; ASIA; AUSTRALIA; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS;

EID: 79957442409     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109711402213     Document Type: Article

References (38)

1. World Health Organisation. HIV /AIDS in the South-East Asia Region. 2009. http://www.searo.who.int/LinkFiles/Publications-HIV-AIDS-Report2009.pdf. Accessed June 15, 2010.
2. Hammer SM, Eron JJ, Jr, Reiss P., et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008 ; 300 (5). 555-570.
3. Kadhiravan T., Sharma SK Mortality of HIV-infected patients in low-income countries. Lancet. 2006 ; 368 (9554). 2207-2207.
4. World Health Organisation. Rapid advice: Antiretroviral therapy for HIV infectionin adults and adolescents. 2009. http://www.who.int/hiv/pub/arv/rapid- advice-art.pdf. Accessed June 15, 2010.
5. Chng WJ, Tan GB, Kuperan P. Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and race and comparison with other published studies. Clin Diagn Lab Immunol. 2004 ; 11 (1). 168-173. (Pubitemid 38090672)
6. Das BR, Bhanushali AA, Khadapkar R., Jeswani KD, Bhavsar M., Dasgupta A. Reference ranges for lymphocyte subsets in adults from western India: influence of sex, age and method of enumeration. Indian J Med Sci. 2008 ; 62 (10). 397-406.
7. Jiang W., Kang L., Lu HZ, et al. Normal values for CD4 and CD8 lymphocyte subsets in healthy Chinese adults from Shanghai. Clin Diagn Lab Immunol. 2004 ; 11 (4). 811-813. (Pubitemid 38944014)
8. Webster HK, Pattanapanyasat K., Phanupak P., et al. Lymphocyte immunophenotype reference ranges in healthy Thai adults: implications for management of HIV/AIDS in Thailand. Southeast Asian J Trop Med Public Health. 1996 ; 27 (3). 418-429. (Pubitemid 126471608)
9. Achhra AC, Zhou J., Dabis F., et al. Difference in absolute CD4+ count according to CD4 percentage between Asian and Caucasian HIV-Infected patients. J AIDS Clinic Res. 2010 ; 1: 101.
10. Egger S., Petoumenos K., Kamarulzaman A., et al. Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD). J Acquir Immune Defic Syndr. 2009 ; 50 (5). 513-520.
11. Australian HIV Observational Database. Rates of combination antiretroviral treatment change in Australia, 1997-2000. HIV Med. 2002 ; 3 (1). 28-36.
12. Zhou J., Kumarasamy N., Ditangco R., et al. The TREAT Asia HIV Observational Database: baseline and retrospective data. J Acquir Immune Defic Syndr. 2005 ; 38 (2). 174-179. (Pubitemid 40189324)
13. Prestage G., Bradley J., Down I., et al. HIV Seroconversion Study. Newly diagnosed men in Australia. 2009. http://www.nchecr.unsw.edu.au/nchecrweb.nsf/ resources/QldSurv/$file/SeroconReportOct09.pdf. Accessed August 9, 2010.
14. Volk JE, Prestage G., Jin F., et al. Risk factors for HIV seroconversion in homosexual men in Australia. Sexual Health. 2006 ; 3 (1). 45-51. (Pubitemid 43269508)
15. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992 ; 41 (RR- 17). 1-19.
16. Egger M., Spycher BD, Sidle J., et al. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-saharan Africa. PLoS Med. 2011 ; 8 (1). e1000390.
17. Brinkhof MW, Pujades-Rodriguez M., Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009 ; 4 (6). e5790.
18. Anglaret Xmdp, Toure Smdm, Gourvellec GM, et al. Impact of Vital Status Investigation Procedures on Estimates of Survival in Cohorts of HIV-Infected Patients From Sub-Saharan Africa. [Report]. JAIDS. 2004 ; 35 (3). 320-323.
19. Braitstein P., Brinkhof MW, Dabis F., et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006 ; 367 (9513). 817-824.
20. Mekonnen Y., Geskus RB, Hendriks JC, et al. Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers. J Infect Dis. 2005 ; 192 (5). 739-748. (Pubitemid 41193071)
21. Brinkhof MWG, Egger M., Schechter M., Dabis F. Mortality of HIV-infected patients in low-income countries-Authors' response. Lancet. 2006 ; 368 (9554). 2207-2208.
22. Zhang F., Dou Z., Ma Y., et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med. 2009 ; 151 (4). 241-251, W-252.
23. Ho C., Lee S., Wong K., Cheng L., Lam M. Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-infected patients. HIV Med. 2007 ; 8 (3). 181-185. (Pubitemid 46915689)
24. Wong KH, Chan KC, Cheng KL, Chan WK, Kam KM, Lee SS Establishing CD4 thresholds for highly active antiretroviral therapy initiation in a cohort of HIV-infected adult Chinese in Hong Kong. AIDS Patient Care STDS. 2007 ; 21 (2). 106-115. (Pubitemid 46394024)
25. Muller M., Wandel S., Colebunders R., Attia S., Furrer H., Egger M. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010 ; 10 (4). 251-261.
26. Ruxrungtham K., Brown T., Phanuphak P. HIV/AIDS in Asia. Lancet. 2004 ; 364 (9428). 69-82. (Pubitemid 38976486)
27. Seyler C., Toure S., Messou E., Bonard D., Gabillard D., Anglaret X. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan. Am J Respir Crit Care Med. 2005 ; 172 (1). 123-127. (Pubitemid 40923324)
28. Manosuthi W., Chaovavanich A., Tansuphaswadikul S., et al. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. J Infect. 2007 ; 55 (5). 464-469. (Pubitemid 47611502)
29. World Health Organization. TB in South-East Asia. 2009. http://www.searo.who.int/EN/Section10/Section2097/Section2100-10639.htm. Accessed April 19, 2010.
30. Osmanov S., Pattou C., Walker N., Schwardlander B., Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr. 2002 ; 29 (2). 184-190. (Pubitemid 34164892)
31. Alaeus A., Lidman K., Bjorkman A., Giesecke J., Albert J. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. AIDS. 1999 ; 13 (8). 901-907. (Pubitemid 29240184)
32. Geretti Anna M., Harrison L., Green H., et al. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis. 2009 ; 48 (9). 1296-1305.
33. Ramalingam S., Kannangai R., Zachariah A., Mathai D., Abraham C. CD4 counts of normal and HIV-infected south Indian adults: do we need a new staging system ? Natl Med J India. 2001 ; 14 (6). 5.
34. Bica I., McGovern B., Dhar R., et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001 ; 32 (3). 492-497. (Pubitemid 32173638)
35. Miller MF, Haley C., Koziel MJ, Rowley CF Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis. 2005 ; 41 (5). 713-720. (Pubitemid 41170361)
36. Inferior Clinical Outcome of the CD4+ Cell Count-Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-up. J Infect Dis. 2008 ; 197 (8). 1145-1155.
37. Achhra AC, Amin J., Law MG, et al. Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients. AIDS. 2010 ; 24 (12). 1877-1886.
38. Baker JV, Peng G., Rapkin J., et al. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS. 2008 ; 22 (7). 841-848. (Pubitemid 351563833)